John S. Lambert

7.5k total citations
215 papers, 4.8k citations indexed

About

John S. Lambert is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, John S. Lambert has authored 215 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Infectious Diseases, 91 papers in Epidemiology and 58 papers in Virology. Recurrent topics in John S. Lambert's work include HIV/AIDS Research and Interventions (62 papers), HIV Research and Treatment (57 papers) and Hepatitis C virus research (47 papers). John S. Lambert is often cited by papers focused on HIV/AIDS Research and Interventions (62 papers), HIV Research and Treatment (57 papers) and Hepatitis C virus research (47 papers). John S. Lambert collaborates with scholars based in Ireland, United States and United Kingdom. John S. Lambert's co-authors include Raphael Dolin, Walter Cullen, E. Richard Stiehm, Fred Valentine, Mindell Seidlin, James Bethel, Mary Glenn Fowler, Lynne Mofenson, D.R. Harris and Jack Moye and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

John S. Lambert

208 papers receiving 4.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John S. Lambert 2.4k 1.7k 1.5k 930 616 215 4.8k
Colette Smith 3.7k 1.5× 2.8k 1.7× 1.6k 1.1× 1.6k 1.8× 502 0.8× 233 6.9k
Andrea Kovács 2.4k 1.0× 1.8k 1.1× 1.7k 1.1× 616 0.7× 590 1.0× 133 4.4k
Sundhiya Mandalia 2.9k 1.2× 1.6k 1.0× 1.6k 1.1× 851 0.9× 362 0.6× 157 5.7k
Audrey L. French 1.8k 0.7× 1.7k 1.0× 926 0.6× 1.0k 1.1× 399 0.6× 183 4.5k
Praphan Phanuphak 4.7k 1.9× 2.8k 1.6× 2.8k 1.8× 898 1.0× 373 0.6× 276 7.4k
Homayoon Farzadegan 2.9k 1.2× 1.7k 1.0× 2.5k 1.6× 542 0.6× 446 0.7× 77 4.9k
Sheldon H. Landesman 3.5k 1.4× 3.1k 1.8× 1.7k 1.1× 913 1.0× 474 0.8× 122 6.4k
Alison Rodger 3.0k 1.2× 2.9k 1.7× 968 0.6× 680 0.7× 946 1.5× 154 5.4k
Richard Marlink 4.2k 1.7× 1.7k 1.0× 3.6k 2.4× 732 0.8× 297 0.5× 128 6.0k
Brian K. Agan 2.2k 0.9× 1.6k 1.0× 1.7k 1.1× 1.1k 1.2× 484 0.8× 167 4.6k

Countries citing papers authored by John S. Lambert

Since Specialization
Citations

This map shows the geographic impact of John S. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Lambert more than expected).

Fields of papers citing papers by John S. Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Lambert. The network helps show where John S. Lambert may publish in the future.

Co-authorship network of co-authors of John S. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Lambert. A scholar is included among the top collaborators of John S. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Lambert. John S. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCormick, P. Aiden, Cillian De Gascun, John S. Lambert, et al.. (2024). Hepatitis C community prevalence is over-estimated: a prospective, birth cohort study. Irish Journal of Medical Science (1971 -). 193(3). 1257–1260. 1 indexed citations
2.
Avramovic, Gordana, et al.. (2024). Biomarker-Based Analysis of Pain in Patients with Tick-Borne Infections before and after Antibiotic Treatment. Antibiotics. 13(8). 693–693. 1 indexed citations
3.
Lambert, John S., et al.. (2024). Scrutinizing Clinical Biomarkers in a Large Cohort of Patients with Lyme Disease and Other Tick-Borne Infections. Microorganisms. 12(2). 380–380. 1 indexed citations
4.
5.
McCombe, Geoff, Davina Swan, John S. Lambert, et al.. (2022). Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis. SHILAP Revista de lepidopterología. 11(2). e35300–e35300. 3 indexed citations
6.
O’Kelly, Brendan, Sean Griffin, Aoife G. Cotter, et al.. (2021). Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave. JAC-Antimicrobial Resistance. 3(2). dlab085–dlab085. 6 indexed citations
7.
McCombe, Geoff, Gordana Avramovic, Des Crowley, et al.. (2021). General practice attendances among patients attending a post-COVID-19 clinic: a pilot study. BJGP Open. 5(3). BJGPO.2021.0016–BJGPO.2021.0016.
8.
9.
McCombe, Geoff, Walter Cullen, John S. Lambert, et al.. (2019). Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series. Journal of Antimicrobial Chemotherapy. 74(Supplement_5). v24–v30. 6 indexed citations
10.
Murtagh, Ross, Davina Swan, Geoff McCombe, et al.. (2018). Hepatitis C Prevalence and Management Among Patients Receiving Opioid Substitution Treatment in General Practice in Ireland: Baseline Data from a Feasibility Study. Interactive Journal of Medical Research. 7(2). e10313–e10313. 7 indexed citations
11.
McCombe, Geoff, Davina Swan, Gordana Avramovic, et al.. (2018). Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care. JMIR Research Protocols. 7(6). e149–e149. 8 indexed citations
12.
O’Halloran, Jane A., Cillian De Gascun, Linda Dunford, et al.. (2011). Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection. Journal of Clinical Virology. 52(2). 151–154. 21 indexed citations
13.
Swan, Davina, Jean Long, Olívia Carr, et al.. (2010). Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration. AIDS Patient Care and STDs. 24(12). 753–762. 162 indexed citations
14.
Coughlan, Suzie, Jonathan Dean, John S. Lambert, et al.. (2009). Phenotypic Characterization of Lymphocytes in HCV/HIV Co-infected Patients. Viral Immunology. 22(1). 39–48. 17 indexed citations
15.
Halfon, P., Fabrice Carrat, Pierre Bédossa, et al.. (2008). 791 IMPACT OF ANTIVIRAL TREATMENT ON NON INVASIVE PREDICTORS OF LIVER FIBROSIS IN HIV-HCV CO-INFECTED PATIENTS: THE FIBROVIC 2 STUDY-ANRS HC02. Journal of Hepatology. 48. S295–S295. 1 indexed citations
16.
Lambert, John S., D.R. Harris, E. Richard Stiehm, et al.. (2003). Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(5). 512–519. 58 indexed citations
17.
Edelman, Daniel C., et al.. (2002). Hepatitis C virus transfusion-transmitted infection in Brazilian cardiac surgery patients.. PubMed. 48(9-10). 529–33. 7 indexed citations
18.
Nogueira, Susie Andries, et al.. (2001). The incidence of GB virus C / hepatitis G virus infection in Brazilian patients who received blood transfusion during cardiac surgery. Journal of Medical Virology. 63(3). 237–241. 2 indexed citations
19.
Lambert, John S., James McNamara, Samuel L. Katz, et al.. (1998). Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(5). 451–461. 25 indexed citations
20.
Maheux, Brigitte, et al.. (1990). [Primary care in Québec: a comparison between private practitioners and physicians working in public community health centers].. PubMed. 81(1). 27–31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colette Smith Breakdown of academic impact, for papers by Andrea Kovács Breakdown of academic impact, for papers by Sundhiya Mandalia Breakdown of academic impact, for papers by Audrey L. French Breakdown of academic impact, for papers by Praphan Phanuphak Breakdown of academic impact, for papers by Homayoon Farzadegan Breakdown of academic impact, for papers by Sheldon H. Landesman Breakdown of academic impact, for papers by Alison Rodger Breakdown of academic impact, for papers by Richard Marlink Breakdown of academic impact, for papers by Brian K. Agan
Rankless by CCL
2026